https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:9567 Wed 11 Apr 2018 15:22:37 AEST ]]> Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:19497 Ex vivo, sepsis-derived interphase neutrophils expressed arginase, metabolised culture L-arginine and suppressed T cell proliferation and CD3 zeta-chain expression. In vivo, in septic shock there was a longitudinal inverse association between interphase neutrophil number and CD3 zeta-chain expression. Depletion or inhibition of interphase neutrophils in vitro restored zeta-chain expression and T cell function. Conclusions: For the first time during an acute human infection, interphase neutrophils that express arginase were found to circulate in sepsis, in proportion to disease severity. These neutrophil-MDSCs impair T cell CD3 zeta-chain expression and T cell function via L-arginine metabolism, and likely contribute to the T cell dysfunction seen in sepsis. Modulation of neutrophil-MDSC or their downstream effects warrant consideration as targets for novel adjunctive therapies in sepsis.]]> Wed 11 Apr 2018 09:14:07 AEST ]]> Allergen-encoding bone marrow transfer inactivates allergic T cell responses, alleviating airway inflammation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31941 Tue 10 Apr 2018 11:22:18 AEST ]]> Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48634 3.5-fold after steroid and ATG treatment. This case illustrates the need to consider this form of steroid resistance in patients failing treatment with corticosteroids. It also highlights the need for both better identification of patients at risk and the development of treatments that involve more specific immune suppression.]]> Mon 03 Apr 2023 10:14:28 AEST ]]>